SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours

A. Khatri, B. W. Williams, J. Fisher, R. C. Brundage, V. J. Gurvich, L. G. Lis, K. M. Skubitz, A. Z. Dudek, E. W. Greeno, R. A. Kratzke, J. K. Lamba, M. N. Kirstein

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science